Malaysian firm Yong Tai Bhd, which has partnered with China-based Shenzhen Kangtai Biological Products Co Ltd (SZKT) to supply Chinese-produced Covid-19 vaccine in Malaysia, is targeting to offer its vaccines to the private sector by September or October.

Yong Tai's chief executive officer Boo Kuang Loon said the group, which has an agreement with SZKT to supply 10 million doses per year with an additional option of 10 million if required, has commenced its trial vaccination.

"We are currently conducting the Phase 3 clinical trial in Malaysia and have made an application to the National Pharmaceutical Regulatory Agency for a...